Cancer in the shadow of the AIDS epidemic in Southern Africa

Oncologist

Volumn 18, Issue 7, 2013, Pages 783-786

  Livingston, Julie ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CANCER PALLIATIVE THERAPY; CD4 LYMPHOCYTE COUNT; CHEMOTHERAPY; CRYOTHERAPY; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; KAPOSI SARCOMA; NEOPLASM; ONCOLOGY WARD; PRIORITY JOURNAL; UTERINE CERVIX CANCER; ACQUIRED IMMUNODEFICIENCY SYNDROME; COMPLICATION; HIV INFECTIONS; MALE; NEOPLASMS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA, SOUTHERN; HIV INFECTIONS; HUMANS; MALE; NEOPLASMS;

EID: 84880681130     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0215     Document Type: Article

References (13)

1. Parkin DM, Sitas F, Chirenje M et al. Part I: Cancer in Indigenous Africas-burden, distribution, and trends. Lancet Oncol 2008;9:683-692.
2. Livingston J. Improvising Medicine: An African Oncology Ward in an Emerging Cancer Epidemic Durham, NC: Duke University Press; 2012.
3. Republic of Botswana and UNDP. Botswana Millenium Development Goals: Status Report 2010. Available at http://web.undp.org/africa/documents/mdg/botswana_2010.pdf. Accessed 24 May 2013.
4. Feigal E, Black J. Cancer and AIDS: National Cancer Institute's Investment in Research. Research Initiative/Treatment Action! Newsletter, Summer 2003.
5. Travis K. Cancer in Africa: health experts aim to curb potential epidemic. J Natl Cancer Inst 2007;99:1146-1147.
6. Meredith S, Shiels R, Pfieffer M et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011;103:753-762.
7. Dryden-Peterson S et al. Malignancies among HIV-infected and HIV-uninfected patients in a Botswana prospective cohort. Poster 902 for the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, March 5-9, 2012.
8. IAEA/PACT in Africa, June 2010. Available at http://www.iaea.org/Publications/Booklets/TreatingCancer/pact0610.pdf. Accessed June 19, 2013.
9. Ramogola-Masire D et al. Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana. Infect Agent Cancer 2010, 5(Suppl 1):A83.
10. Ramogola-Masire D, McGrath CM, Barnhart KT et al. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana. Int J Gynecol Pathol. 2011;30:591-596.
11. Macleod IJ, O'Donnell B, Moyo S et al. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana. J Med Virol. 2011;83:1689-1695.
12. Haug CJ. Human papillomavirus vaccination---Reasons for caution. N Engl J Med. 2008;359:861-862.
13. Ramogola-Masire D et al. Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. J Acquir Immune Defic Syndr. 2012;59:308-313.